Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease

被引：22

作者：

Scoazec, JY ^{[1
]}

Krolak-Salmon, P

Casez, O

Besson, G

Thobois, S

Kopp, N

Perret-Liaudet, A

Streichenberger, N

机构：

[1] Hop Edouard Herriot, Serv Anat Pathol, Lyon, France

[2] Hop Neurol & Neurochirurg, Ctr Diagnost Traitement & Prevent Malad Prions, Lyon, France

[3] Hop Neurol & Neurochirurg, Serv Neuropathol Biochim, Lyon, France

[4] CHU Grenoble, Serv Neurol, F-38043 Grenoble, France

[5] Hop Neurol & Neurochirurg, Serv Neurol D, Lyon, France

来源：

ANNALS OF NEUROLOGY | 2003年 / 53卷 / 04期

关键词：

D O I：

10.1002/ana.10530

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：546 / 547

页数：2

共 5 条

[1] Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model [J].

Collins, SJ ;

Lewis, V ;

Brazier, M ;

Hill, AF ;

Fletcher, A ;

Masters, CL .

ANNALS OF NEUROLOGY, 2002, 52 (04) :503-506

[2] CONSENSUS MEETINGS ON - CAUSALITY ASSESSMENT OF DRUG-INDUCED LIVER-INJURY [J].

DANAN, G .

JOURNAL OF HEPATOLOGY, 1988, 7 (01) :132-136

[3] Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation [J].

Doh-Ura, K ;

Iwaki, T ;

Caughey, B .

JOURNAL OF VIROLOGY, 2000, 74 (10) :4894-4897

[4] Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease [J].

Korth, C ;

May, BCH ;

Cohen, FE ;

Prusiner, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9836-9841

[5]

Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0

← 1 →